Clover Biopharmaceuticals, Ltd announced that it will receive $320,713 in funding on April 2, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.345 HKD | -4.17% | +6.15% | -44.35% |
Apr. 12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
Apr. 08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.35% | 59.65M | |
-2.47% | 103B | |
+1.91% | 95.28B | |
+1.46% | 22.15B | |
-15.70% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.68% | 16.05B | |
+5.34% | 13.68B | |
+34.93% | 12.17B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Biopharmaceuticals, Ltd. announced that it expects to receive $0.320713 million in funding